Detalhe da pesquisa
1.
Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol.
Cost Eff Resour Alloc
; 21(1): 55, 2023 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37612702
2.
A comprehensive transcriptional map of primate brain development.
Nature
; 535(7612): 367-75, 2016 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27409810
3.
Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab.
Oncology (Williston Park)
; 35(12): 804-811, 2021 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089000
4.
Conserved molecular signatures of neurogenesis in the hippocampal subgranular zone of rodents and primates.
Development
; 140(22): 4633-44, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24154525
5.
Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy in the USA.
Pharmacoeconomics
; 42(5): 569-582, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300452
6.
Adherence and Persistence Among Risdiplam-Treated Individuals with Spinal Muscular Atrophy: A Retrospective Claims Analysis.
Adv Ther
; 41(6): 2446-2459, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709394
7.
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States.
J Med Econ
; 27(1): 766-776, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712895
8.
Divergent and nonuniform gene expression patterns in mouse brain.
Proc Natl Acad Sci U S A
; 107(44): 19049-54, 2010 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20956311
9.
Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States.
J Manag Care Spec Pharm
; 27(11): 1532-1544, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34714110
10.
Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States.
Pharmacoeconomics
; 38(9): 941-951, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383129